Regardless of prognosis, panel deemed it appropriate to continue opioids, increase monitoring, and avoid opioid tapering
However, cannabis and cannabis-based medicines may aid certain clinical conditions
The nasal spray version of naloxone will be available at select retailers for $44.99 for a box of two doses
No impact on receipt of opioid or nonopioid pain treatment seen among patients with chronic noncancer pain
Beneficial effects seen for 12 weekly sessions of cognitive behavioral therapy and/or pharmacotherapy using stepped approach
Adults identifying as bisexual or 'something else' have highest prevalence of chronic pain
Improvement observed across a range of health conditions, mostly sustained over time
Increase in proportion of patients achieving ≥15 percent reduction in daily morphine equivalent dose, ≥2-point reduction in pain intensity
Co-occurrence of symptoms also very common across cancer types
Strong recommendation made against long-term opioid therapy, especially for younger age groups, those with substance use disorder